Related Experiment Video
Updated: Oct 30, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up
Ismail M Osmanov1,2,3, Ekaterina Spiridonova4,3, Polina Bobkova4,3
1Z.A. Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.
Insights
A quarter of children experienced persistent symptoms months after COVID-19 hospitalization. Older age and allergic diseases were linked to increased risk of these long-term symptoms in children.
Area of Science:
- Pediatric infectious diseases
- Long-term health outcomes
- Epidemiology of emerging infections
Background:
- Long-term effects of COVID-19 in children are not well understood.
- Previous hospitalizations for COVID-19 in pediatric populations require further investigation.
- Assessing sequelae in children post-COVID-19 infection is crucial for public health.
Purpose of the Study:
- To evaluate the long-term health outcomes in children after hospital admission for COVID-19.
- To identify risk factors associated with persistent symptoms in pediatric COVID-19 survivors.
- To characterize the nature and prevalence of long-term sequelae in children post-COVID-19.
Main Methods:
- Prospective cohort study including children (≤18 years) hospitalized with confirmed COVID-19.
- Follow-up assessments conducted via telephone interviews using the ISARIC COVID-19 Health and Wellbeing Follow-up Survey for Children.
- Persistent symptoms defined as those lasting >5 months and categorized by affected systems.
Main Results:
- 61% of eligible children (518/853) participated in the follow-up.
- 24.3% of participants reported persistent symptoms, most commonly fatigue, sleep disturbances, and sensory problems.
- Older age (6-18 years) and a history of allergic diseases were significant risk factors for persistent symptoms.
Conclusions:
- Persistent symptoms affect a significant proportion of children months after acute COVID-19 hospitalization.
- Multisystem involvement was observed in nearly 10% of children with persistent symptoms.
- Older children and those with allergic conditions face a higher risk of prolonged symptoms post-COVID-19.
Background:
The long-term sequelae of coronavirus disease 2019 (COVID-19) in children remain poorly characterised. This study aimed to assess long-term outcomes in children previously hospitalised with COVID-19 and associated risk factors.
Methods:
This is a prospective cohort study of children (≤18 years old) admitted to hospital with confirmed COVID-19. Children admitted between 2 April 2020 and 26 August 2020 were included. Telephone interviews used the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Health and Wellbeing Follow-up Survey for Children. Persistent symptoms (>5 months) were further categorised by system(s) involved.
Results:
518 out of 853 (61%) eligible children were available for the follow-up assessment and included in the study. Median (interquartile range (IQR)) age was 10.4 (3-15.2) years and 270 (52.1%) were girls. Median (IQR) follow-up since hospital discharge was 256 (223-271) days. At the time of the follow-up interview 126 (24.3%) participants reported persistent symptoms, among which fatigue (53, 10.7%), sleep disturbance (36, 6.9%) and sensory problems (29, 5.6%) were the most common. Multiple symptoms were experienced by 44 (8.4%) participants. Risk factors for persistent symptoms were: older age "6-11 years" (OR 2.74, 95% CI 1.37-5.75) and "12-18 years" (OR 2.68, 95% CI 1.41-5.4), and a history of allergic diseases (OR 1.67, 95% CI 1.04-2.67).
Conclusions:
A quarter of children experienced persistent symptoms months after hospitalisation with acute COVID-19 infection, with almost one in 10 experiencing multisystem involvement. Older age and allergic diseases were associated with higher risk of persistent symptoms at follow-up.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

